Harbin Gloria Pharmaceuticals (002437) — Capital Reinvestment Ratio
Harbin Gloria Pharmaceuticals (002437) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥182.89 Million) in capital expenditures (CN¥4.26 Million). Check Harbin Gloria Pharmaceuticals (002437) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Harbin Gloria Pharmaceuticals Capital Reinvestment Ratio (2007–2025)
This chart tracks Harbin Gloria Pharmaceuticals's Capital Reinvestment Ratio across 19 annual periods. For the full cash flow conversion analysis, see Harbin Gloria Pharmaceuticals cash conversion from operations.
Annual Capital Reinvestment Ratio for Harbin Gloria Pharmaceuticals (2007–2025)
Year-by-year Capital Reinvestment Ratio for Harbin Gloria Pharmaceuticals from 2007 to 2025. See how much free cash does Harbin Gloria Pharmaceuticals generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥273.36 Million | CN¥23.81 Million | ▼ -43.1% |
| 2024 | 0.15x | CN¥410.94 Million | CN¥62.90 Million | ▲ +41.7% |
| 2023 | 0.11x | CN¥274.18 Million | CN¥29.62 Million | ▼ -14.4% |
| 2022 | 0.13x | CN¥261.62 Million | CN¥33.01 Million | ▲ +0.3% |
| 2021 | 0.13x | CN¥274.18 Million | CN¥34.51 Million | ▼ -96.3% |
| 2020 | 3.42x | CN¥12.76 Million | CN¥43.66 Million | ▲ +4211.5% |
| 2019 | 0.08x | CN¥610.37 Million | CN¥48.43 Million | ▼ -11.6% |
| 2018 | 0.09x | CN¥1.16 Billion | CN¥104.34 Million | ▼ -69.9% |
| 2017 | 0.30x | CN¥651.80 Million | CN¥194.63 Million | ▲ +67.6% |
| 2016 | 0.18x | CN¥1.04 Billion | CN¥185.34 Million | ▼ -55.8% |
| 2015 | 0.40x | CN¥702.05 Million | CN¥283.10 Million | ▲ +115.9% |
| 2014 | 0.19x | CN¥674.04 Million | CN¥125.89 Million | ▼ -48.2% |
| 2013 | 0.36x | CN¥453.02 Million | CN¥163.35 Million | ▼ -48.6% |
| 2012 | 0.70x | CN¥205.89 Million | CN¥144.37 Million | ▼ -46.0% |
| 2011 | 1.30x | CN¥128.61 Million | CN¥166.90 Million | ▼ -39.3% |
| 2010 | 2.14x | CN¥112.59 Million | CN¥240.88 Million | ▲ +494.5% |
| 2009 | 0.36x | CN¥170.82 Million | CN¥61.47 Million | ▼ -45.4% |
| 2008 | 0.66x | CN¥57.81 Million | CN¥38.08 Million | ▲ +161.3% |
| 2007 | 0.25x | CN¥52.26 Million | CN¥13.17 Million | — |